Montis Biosciences

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Detlev Biniszkiewicz",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "end_of_term",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2025-04-24",
      "evidence_quote": "De vergadering neemt kennis van en aanvaardt het ontslag van Detlev Biniszkiewicz als bestuurder van de vennootschap met ingang van 24 april 2025.",
      "decharge_status": "provisional",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Detlev Biniszkiewicz",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent voorlopige kwijting aan de ontslagnemende bestuurder voor de uitoefening van zijn mandaat.",
      "decharge_status": "provisional",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "medewerker",
      "person": {
        "rrn": null,
        "name": "Nathalie Dubois",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": null,
      "statutory": "niet_statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "aan mevrouw Nathalie Dubois, mevrouw Ekaterina Em en elke andere medewerker van het kantoor van de ondergetekende notaris, afzonderlijk optredend, voor het opstellen van de geco\u00F6rdineerde tekst van de statuten.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "medewerker",
      "person": {
        "rrn": null,
        "name": "Ekaterina Em",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": null,
      "statutory": "niet_statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "aan mevrouw Nathalie Dubois, mevrouw Ekaterina Em en elke andere medewerker van het kantoor van de ondergetekende notaris, afzonderlijk optredend, voor het opstellen van de geco\u00F6rdineerde tekst van de statuten.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": "Samuel WYNANT",
    "firm_city": null,
    "firm_name": "Van Halteren Notarissen",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-07-09",
    "filing_date": "2025-07-04",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "buitengewone_algemene_vergadering",
      "date": "2025-06-30",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2024-06-26",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2024-08-30",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-06-17",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-06-17",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-06-17",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-06-17",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-06-17",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel WYNANT",
    "org_rep_person_name": null,
    "person_role_at_subject": "notaris"
  },
  "co_filed_documents": [
    "uitgifte",
    "volmachten",
    "verslag",
    "aanwezigheidslijst"
  ],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Detlev Biniszkiewicz",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Samuel WYNANT",
    "firm_city": null,
    "firm_name": "Van Halteren Notarissen",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-07-09",
    "filing_date": "2025-07-04",
    "act_kind_objet": "DIVERSEN, ONTSLAGEN, BENOEMINGEN"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-06-30",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [],
    "exchange_ratio": null,
    "legal_articles": [
      "5:102"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": null,
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel WYNANT",
    "org_rep_person_name": null
  },
  "summary_narrative": "De algemene vergadering van Montis Biosciences heeft een verslag goedgekeurd over voorgestelde wijzigingen van aandelenrechten. De vergadering beslist ook de voorwaarden van de Bridge Loan Inschrijvingsrechten opnieuw te wijzigen. Daarnaast wordt het ontslag van bestuurder Detlev Biniszkiewicz aanvaard en verleend hij voorlopige kwijting.",
  "co_filed_documents": [
    "uitgifte",
    "volmachten",
    "verslag",
    "aanwezigheidslijst"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}

{
  "stage": null,
  "notary": {
    "name": "Samuel WYNANT",
    "firm_city": null,
    "firm_name": "Van Halteren Notarissen",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-07-09",
    "filing_date": "2025-07-04",
    "act_kind_objet": "DIVERSEN, ONTSLAGEN, BENOEMINGEN"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-06-30",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0730.979.429",
        "name": "Montis Biosciences",
        "role": "other",
        "address": "Gaston Geenslaan 3, 3001 Leuven",
        "is_foreign": false,
        "legal_form": "BV",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "5:102"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "De wijziging van de voorwaarden en modaliteiten van de Bridge Loan Inschrijvingsrechten op aandelen, zoals vastgesteld bij besluiten van de algemene vergadering van 26 juni 2024 en 30 augustus 2024, en gewijzigd bij akte van 30 augustus 2024.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel WYNANT",
    "org_rep_person_name": null
  },
  "summary_narrative": "De buitengewone en bijzondere algemene vergadering van aandeelhouders van Montis Biosciences (BV) op 30 juni 2025 heeft besloten de voorwaarden van de Bridge Loan Inschrijvingsrechten op aandelen opnieuw te wijzigen, op basis van een bijzonder verslag van het bestuursorgaan. Het bestuur heeft het verslag opgemaakt overeenkomstig artikel 5:102, tweede lid, van het Wetboek van Vennootschappen en Verenigingen. De vergadering nam ook kennis van het ontslag van Detlev Biniszkiewicz als bestuurder met ingang van 24 april 2025 en verleende voorlopige kwijting. Daarnaast verleende de vergadering bevoe",
  "co_filed_documents": [
    "uitgifte",
    "volmachten",
    "verslag",
    "aanwezigheidslijst"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}

{
  "stage": null,
  "notary": {
    "name": "Samuel Wynant",
    "firm_city": null,
    "firm_name": "Van Halteren Notarissen",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-09-04",
    "filing_date": "2024-09-02",
    "act_kind_objet": "Gaston Geenslaan 3"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-08-30",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0730.979.429",
        "name": "Montis Biosciences",
        "role": "other",
        "address": "Gaston Geenslaan 3, 3001 Leuven",
        "is_foreign": false,
        "legal_form": "BV",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "De actie betreft wijzigingen in de voorwaarden van inschrijvingsrechten op aandelen en de uitgifte van nieuwe inschrijvingsrechten met het doel van het cre\u00EBren van preferente aandelen. Er vindt geen overdracht van patrimoine plaats.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel Wynant",
    "org_rep_person_name": null
  },
  "summary_narrative": "De buitengewone algemene vergadering van aandeelhouders van Montis Biosciences besloot de voorwaarden van de inschrijvingsrechten op aandelen, uitgegeven bij besluit van 26 juni 2024, te wijzigen en een nieuw inschrijvingsrecht uit te geven, met voorwaardelijke uitgifte van preferente aandelen. De besluiten zijn voorwaardelijk aan de uitoefening van het inschrijvingsrecht.",
  "co_filed_documents": [
    "uitgifte",
    "volmachten",
    "verslagen"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}

{
  "stage": null,
  "notary": {
    "name": "Samuel Wynant",
    "firm_city": null,
    "firm_name": "Van Halteren Notarissen",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-09-04",
    "filing_date": "2024-09-02",
    "act_kind_objet": "Gaston Geenslaan 3"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-08-30",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0730.979.429",
        "name": "Montis Biosciences",
        "role": "contributor",
        "address": "Gaston Geenslaan 3, 3001 Leuven",
        "is_foreign": false,
        "legal_form": "BV",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": null,
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel Wynant",
    "org_rep_person_name": null
  },
  "summary_narrative": "De buitengewone algemene vergadering van aandeelhouders van Montis Biosciences besloot de voorwaarden van de inschrijvingsrechten op aandelen te wijzigen en een inschrijvingsrecht op aandelen uit te geven, voorwaardelijk aan de uitoefening van het inschrijvingsrecht.",
  "co_filed_documents": [
    "uitgifte",
    "volmachten",
    "verslagen"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "stage": null,
  "notary": {
    "name": "Samuel Wynant",
    "firm_city": null,
    "firm_name": "Van Halteren, Geassocieerde Notarissen",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-07-02",
    "filing_date": "2024-06-27",
    "act_kind_objet": "3001 Leuven"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-06-26",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0730.979.429",
        "name": "Montis Biosciences",
        "role": "other",
        "address": "Gaston Geenslaan 3, 3001 Leuven",
        "is_foreign": false,
        "legal_form": "BV",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Het gaat om de uitgifte van aandelen en inschrijvingsrechten in het kader van een inschrijvingsplan, met voorbehoud van het voorkeurrecht van bestaande aandeelhouders.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel Wynant",
    "org_rep_person_name": null
  },
  "summary_narrative": "De buitengewone algemene vergadering van aandeelhouders van Montis Biosciences BV heeft besloten tot de uitgifte van inschrijvingsrechten op aandelen en het voorwaardelijk uitgeven van aandelen aan de houders van die rechten, met afstand van het voorkeurrecht door de bestaande aandeelhouders. De akte is op 26 juni 2024 opgemaakt door notaris Samuel Wynant te Brussel.",
  "co_filed_documents": [
    "uitgifte",
    "volmachten",
    "aanwezigheidslijst",
    "verslagen"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "stage": null,
  "notary": {
    "name": "Samuel Wynant",
    "firm_city": null,
    "firm_name": "Van Halteren, Geassocieerde Notarissen",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-07-02",
    "filing_date": "2024-06-27",
    "act_kind_objet": "3001 Leuven"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2024-06-26",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0730.979.429",
        "name": "Montis Biosciences",
        "role": "other",
        "address": "Gaston Geenslaan 3",
        "is_foreign": false,
        "legal_form": "BV",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": null,
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel Wynant",
    "org_rep_person_name": null
  },
  "summary_narrative": "De gewone en buitengewone algemene vergadering van aandeelhouders van de besloten vennootschap Montis Biosciences werd gehouden. De vergadering heeft besloten om een aantal inschrijvingsrechten op aandelen uit te geven en hetzelfde aantal aandelen voorwaardelijk uit te geven aan de uitoefening van die rechten, inclusief afstand van het voorkeurrecht door bestaande aandeelhouders.",
  "co_filed_documents": [
    "uitgifte",
    "volmachten",
    "aanwezigheidslijst",
    "verslagen"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "AXXIS V \u0026 C BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BDO BEDRIJFSREVISOREN BV",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "MONTIS BIOSCIENCES"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "Gaston Geenslaan 3, 3001 Leuven, Belgi\u00EB",
        "city": "Leuven",
        "region": "vlaams_gewest",
        "street": "Gaston Geenslaan",
        "country": "BE",
        "postcode": "3001",
        "box_number": null,
        "street_number": "3",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Gaston Geenslaan 3001 Leuven",
        "city": "Leuven",
        "region": "vlaams_gewest",
        "street": "Gaston Geenslaan",
        "country": "BE",
        "postcode": "3001",
        "box_number": null,
        "street_number": "3001",
        "locality_suffix": null
      },
      "effective_date": "2022-10-25",
      "evidence_quote": "De Raad van Bestuur besluit unaniem om de verplaatsing van de zetel van de Vennootschap naar Gaston Geenslaan 3, 3001 Leuven, Belgi\u00EB, goed te keuren.",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "Samuel Wynant",
    "firm_city": null,
    "firm_name": "Van Halteren Notaries-Notarissen",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2022-11-08",
    "filing_date": "2022-11-04",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "date": "2022-10-25",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Van Halteren Notaries-Notarissen",
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "Uittreksel uit de notulen van de vergadering van de Raad van Bestuur",
    "Volmacht aan bestuurders en medewerkers notariskantoor"
  ]
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "Gaston Geenslaan 3, 3001 Leuven, Belgi\u00EB",
        "city": "Leuven",
        "region": "vlaams_gewest",
        "street": "Gaston Geenslaan",
        "country": "BE",
        "postcode": "3001",
        "box_number": null,
        "street_number": "3",
        "locality_suffix": null
      },
      "old_address": null,
      "effective_date": null,
      "evidence_quote": "De Raad van Bestuur besluit unaniem om de verplaatsing van de zetel van de Vennootschap naar Gaston Geenslaan 3, 3001 Leuven, Belgi\u00EB, goed te keuren.",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": true,
      "old_address_source": "inferred",
      "statute_clause_text": null,
      "statute_article_number": 2,
      "effective_date_qualifier": "immediate",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "Samuel Wynant",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Luik",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2022-11-08",
    "filing_date": "2022-11-04",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "date": "2022-10-25",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Van Halteren Notaries-Notarissen",
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "Bijlagen bij het Belgisch Staatsblad - 08/11/2022 - Annexes du Moniteur belge",
    "Mod PDF 19.01"
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder en dagelijks bestuurder",
      "person": {
        "rrn": null,
        "name": "PLATYNEURON CONSULTING BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sohaib Mir",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Preferent bestuurder",
      "person": {
        "rrn": null,
        "name": "Martin GRAEME",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "MONTIS BIOSCIENCES"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences"
  },
  "legal_form_change": {
    "new": "Besloten Vennootschap",
    "old": "Besloten Vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": null,
      "delta_eur": 7000000.0,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "Preferente",
        "n_new_shares": 5833333,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 1.2
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 7000000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": 5833333,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "Gewone",
        "n_new_shares": null,
        "with_new_shares": null,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "Preferente",
        "n_new_shares": null,
        "with_new_shares": null,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "Gewone",
        "n_new_shares": null,
        "with_new_shares": null,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "Gewone",
        "n_new_shares": null,
        "with_new_shares": null,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Samuel Wynant",
    "firm_city": null,
    "firm_name": "Van Halteren, Geassocieerde Notarissen",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2022-04-01",
    "filing_date": "2022-03-30",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2022-03-29",
    "unanimous": true,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "BDO Bedrijfsrevisoren",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "Veerle Catry"
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences",
    "legal_form": "BV",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition",
    "volmachten",
    "verslagen",
    "bijgewerkte tekst der statuten"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": null,
      "class_name": "Preferente Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": null,
      "class_name": "Gewone Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 7000000,
      "delta_eur": null,
      "before_eur": null,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences"
  },
  "legal_form_change": {
    "new": "Besloten Vennootschap",
    "old": "Besloten Vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "3001 LEUVEN, Gaston Geenslaan 1",
        "city": "Leuven",
        "region": "vlaams_gewest",
        "street": "Gaston Geenslaan",
        "country": "BE",
        "postcode": "3001",
        "box_number": null,
        "street_number": "1",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "1860 MEISE, Brusselsesteenweg 11",
        "city": "Meise",
        "region": "vlaams_gewest",
        "street": "Brusselsesteenweg",
        "country": "BE",
        "postcode": "1860",
        "box_number": null,
        "street_number": "11",
        "locality_suffix": null
      },
      "effective_date": "2020-10-07",
      "evidence_quote": "De raad van bestuur d.d. 07.10.2020 heeft beslist om de zetel van de vennootschap te verplaatsen naar 3001 LEUVEN, Gaston Geenslaan 1 met ingang van heden.",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "act_body",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "immediate",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    },
    {
      "kind": "zetel_initial_set",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "1860 MEISE, Brusselsesteenweg 11",
        "city": "Meise",
        "region": "vlaams_gewest",
        "street": "Brusselsesteenweg",
        "country": "BE",
        "postcode": "1860",
        "box_number": null,
        "street_number": "11",
        "locality_suffix": null
      },
      "old_address": null,
      "effective_date": "2020-10-07",
      "evidence_quote": "Volledig adres v.d. zetel: 1860 MEISE, Brusselsesteenweg 11",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "immediate",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "Luc DOCHEZ",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Brussel",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2020-12-07",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "date": "2020-10-07",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "MONTIS BIOSCIENCES",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "Bijlagen bij het Belgisch Staatsblad - 14/12/2020"
  ]
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "CEO bestuurder",
      "person": {
        "rrn": null,
        "name": "PLATYNEURON CONSULTING BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "dagelijks bestuurder",
      "person": {
        "rrn": null,
        "name": "PLATYNEURON CONSULTING BV",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "MONTIS BIOSCIENCES"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "Preferent Bestuurder",
      "person": {
        "rrn": null,
        "name": "Rana Al-Hallaq",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "Preferent Bestuurder",
      "person": {
        "rrn": null,
        "name": "Luc Dochez",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Preferent Bestuurder",
      "person": {
        "rrn": null,
        "name": "Ellie McGuire",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Preferent Bestuurder",
      "person": {
        "rrn": null,
        "name": "Sohaib Mir",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Gewoon Bestuurder",
      "person": {
        "rrn": null,
        "name": "Griet Vanpoucke",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Onafhankelijk Bestuurder",
      "person": {
        "rrn": null,
        "name": "Detlev Biniszkiewicz",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Preferent Bestuurder",
      "person": {
        "rrn": null,
        "name": "Luc Dochez",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Gewoon Bestuurder",
      "person": {
        "rrn": null,
        "name": "Griet Vanpoucke",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences"
  },
  "legal_form_change": {
    "new": "BV",
    "old": "Besloten vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1325000,
      "delta_eur": null,
      "before_eur": null,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 662500,
      "delta_eur": null,
      "before_eur": null,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "name_full": "Montis Biosciences"
  }
}

{
  "notary": {
    "name": "Samuel WYNANT",
    "firm_city": null,
    "firm_name": "Van Halteren, Geassocieerde Notarissen",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2019-07-26",
    "filing_date": "2019-07-24",
    "act_kind_objet": "Onderwerp akte:",
    "is_private_deed": false
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-07-19",
    "unanimous": true
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1959-12-08",
        "name": "Professor Peter Carmeliet",
        "niss": null,
        "address": "Sappellenbos 10, 3052 Blanden",
        "nationality": null,
        "place_of_birth": null
      },
      "share_class": null,
      "partner_role": "null",
      "contribution_type": "geld",
      "amount_paid_in_eur": 25000.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 250000,
      "amount_subscribed_eur": 25000.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1974-11-08",
        "name": "Luc Madeleine DOCHEZ",
        "niss": null,
        "address": "Klein Vilvoordestraat 8, 3078 Meerbeek",
        "nationality": null,
        "place_of_birth": null
      },
      "share_class": null,
      "partner_role": "null",
      "contribution_type": "geld",
      "amount_paid_in_eur": 25000.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 250000,
      "amount_subscribed_eur": 25000.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": "0456.343.923",
        "name": "VIB (Vlaams Instituut voor Biotechnologie)",
        "address": "9052 Gent (Zwijnaarde), Rijvisschestraat 120",
        "country": "BE",
        "legal_form": "VZW",
        "foreign_register_name": null,
        "foreign_register_number": null
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": "null",
      "contribution_type": "natura",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 2500000,
      "amount_subscribed_eur": 250000.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": "0728.608.867",
        "name": "Droia Invest II S.C.Sp",
        "address": "2520 Luxembourg (Groothertogdom Luxemburg), 35, All\u00E9e Scheffer",
        "country": "LU",
        "legal_form": "S.C.Sp",
        "foreign_register_name": "RCS Luxembourg",
        "foreign_register_number": "B226585"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": "null",
      "contribution_type": "natura",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 1500000,
      "amount_subscribed_eur": 150000.0,
      "is_anonymous_silent_partner": false
    }
  ],
  "voorwerp": {
    "full_text": "De Vennootschap heeft tot voorwerp, in Belgi\u00EB en in het buitenland, zowel voor eigen rekening als voor rekening van derden, alleen of in participatie met derden:\n \u2022 onderzoek, ontwikkeling, productie, marketing en exploitatie van biologische, chemische of andere producten, processen en technologie\u00EBn in de life sciences sector in het algemeen en oncologie in het bijzonder;\n \u2022 de verwerving, het bezit, het onderzoek, de ontwikkeling, de verkoop, de aankoop, het beheer, de onderhandeling, de commercialisering en het in licentie geven of nemen van farmaceutische, diagnostische, biologische en biotechnologische bestanddelen, producten en hulpmiddelen, in de ruimste zin;\n \u2022 het verschaffen van diensten in de ruimste zin op het gebied van onderzoek en ontwikkeling, aan farmaceutische, diagnostische, biologische en biotechnologische ondernemingen en activiteiten alsook aan academische en wetenschappelijke instellingen;\n \u2022 de verwerving, het bezit, het onderzoek, de ontwikkeling, de verkoop, de aankoop, het beheer, de onderhandeling, de commercialisering en het in licentie geven of nemen van intellectuele eigendomsrechten (zoals octrooien) in de medische sector in de ruimste zin.\nZij kan alle verrichtingen, in het bijzonder industri\u00EBle of handels-, roerende of onroerende verrichtingen doen, in rechtstreeks of onrechtstreeks, geheel of gedeeltelijk verband met \u00E9\u00E9n of ander onderdeel van haar voorwerp, of die van aard zouden zijn de verwezenlijking ervan uit te breiden of te vergemakkelijken.\nZij kan op alle wijzen deelnemen in alle vennootschappen of ondernemingen met een gelijk of aanverwant voorwerp of waarvan het voorwerp, zelfs onrechtstreeks, van aard zou zijn de verwezenlijking van het hare te vergemakkelijken.\nZij kan eveneens alle overeenkomsten van samenwerking, rationalisatie, vereniging of andere afsluiten met dergelijke vennootschappen of ondernemingen.\nZij mag zowel tot waarborg van eigen verbintenissen als tot waarborg van verbintenissen van derden borg stellen, onder meer door haar goederen in hypotheek of in pand te geven, inclusief de eigen handelszaak.\nZij mag de functie van bestuurder, zaakvoerder en vereffenaar uitoefenen.\nIn het geval de verrichting van bepaalde handelingen zou onderworpen zijn aan voorafgaande voorwaarden inzake toegang tot het beroep, zal de Vennootschap haar optreden, wat betreft de verrichting van deze handelingen, aan de vervulling van deze voorwaarden ondergeschikt maken.",
    "is_lucrative": true,
    "short_summary": "Onderzoek, ontwikkeling, productie, marketing en exploitatie van biologische, chemische of andere producten, processen en technologie\u00EBn in de life sciences sector, met name oncologie."
  },
  "governance": {
    "organ_kind": "raad_van_bestuur",
    "n_directors_max": 3,
    "n_directors_min": 2,
    "representation_clause": "twee bestuurders gezamenlijk",
    "co_signature_threshold_eur": null
  },
  "fiscal_year": {
    "end_mm_dd": "12-31",
    "start_mm_dd": "01-01",
    "first_exercise_end_date": "2020-12-31",
    "is_prolonged_first_exercise": false
  },
  "agm_schedule": {
    "time": "14:00",
    "month": 6,
    "rule_text": "eerste woensdag van de maand juni"
  },
  "founding_event": {
    "n_shares_total": 4500000,
    "n_share_classes": 1,
    "bank_attestation": {
      "date": "2019-07-17",
      "bank_name": "BNP Paribas Fortis SA/NV",
      "amount_eur": 50000.0,
      "iban_masked": "BE43 3632 6778 4001"
    },
    "amount_paid_in_eur": 50000.0,
    "incorporation_date": "2019-07-19",
    "amount_subscribed_eur": 450000.0,
    "art_5_8_no_payment_due": false,
    "pre_incorporation_activity_from_date": null
  },
  "subject_company": {
    "kbo": "0730.979.429",
    "email": null,
    "region": "vlaams_gewest",
    "website": null,
    "name_full": "Montis Biosciences",
    "legal_form": "BV",
    "name_abbreviated": null,
    "zetel_address_raw": "1860 Meise, Brusselsesteenweg 11",
    "equity_account_type": "available",
    "_kbo_filled_from_list": true
  },
  "initial_directors": [
    {
      "kind": "natural_person",
      "person": {
        "name": "Luc Madeleine DOCHEZ",
        "address": "Klein Vilvoordestraat 8, 3078 Meerbeek"
      },
      "via_org": null,
      "role_sub": "enige_bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": null,
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": null
    },
    {
      "kind": "natural_person",
      "person": {
        "name": "Griet Vanpoucke",
        "address": null
      },
      "via_org": null,
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": null,
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": null
    }
  ],
  "co_filed_documents": [
    "expedition",
    "statuten",
    "volmacht",
    "verslag van de oprichters",
    "bankattest"
  ],
  "post_incorporation_mandates": [
    {
      "kind": "volmacht_kbo",
      "holder_org_kbo": null,
      "holder_org_name": "PVMD Bedrijfsrevisoren BV CVBA",
      "with_substitution": false,
      "holder_person_name": "Alain Chaerels"
    }
  ]
}